By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Acumen Pharmaceuticals Inc. 

4435 North First Street,
Suite 360
Livermore  California  94551  U.S.A.
Phone: 925-368-8508 Fax: 925-605-3813




Merck & Co.  Alzheimer's disease

Company News
Acumen Pharmaceuticals Inc. Announces First Closing of $20 Million Series A Financing 4/25/2013 10:08:28 AM
Merck Sharp & Dohme (MRK) Axes Alzheimer Deal with Acumen Pharmaceuticals Inc. 12/21/2011 7:42:30 AM
Acumen Pharmaceuticals Inc. Co-Founders Link Alzheimer's Cause to Insulin Resistance 10/22/2007 10:07:07 AM
Acumen Pharmaceuticals Inc. Announces Milestone Achievement In Collaboration With Merck & Co., Inc. (MRK) (Jobs) 1/23/2007 10:50:47 AM
Acumen Pharmaceuticals Inc. Announces Amended Agreement With Merck & Co., Inc. (MRK) To Include Exclusive Diagnostic Rights 11/27/2006 3:39:57 PM
Acumen Pharmaceuticals Inc. Names Dr. William F. Goure Chief Operating Officer 11/6/2006 1:38:31 PM
Acumen Pharmaceuticals Inc. Joins Neurotechnology Industry Organization 10/23/2006 10:29:01 AM
Company Profile For Acumen Pharmaceuticals Inc.10/19/2005 5:09:42 PM
Acumen And Merck & Co. (MRK) Enter Into Alzheimer's Collaboration; Acumen Pharmaceuticals Inc. Will Be Eligible To Receive $48 Million10/19/2005 5:09:40 PM
Acumen Pharmaceuticals Inc. Receives SBIR Award From National Institute On Aging10/19/2005 5:09:07 PM